| Literature DB >> 30021651 |
Magdalena Del Rocío Sevilla-González1,2, Carlos A Aguilar-Salinas1,3,4, Liliana Muñóz-Hernández1,5, Paloma Almeda-Valdés1,3, Roopa Mehta1,2,3, Rafael Zubirán1, Omar Yaxmehen Bello-Chavolla1,6, Donaji V Gómez-Velasco1,3, Arsenio Vargas-Vázquez1,6, Tannia Viveros-Ruíz1, Alexandro J Martagón-Rosado1,4, Ivette Cruz-Bautista7,8,9.
Abstract
BACKGROUND: Postprandial lipemia is an important cardiovascular risk factor. The assessment of postprandial lipid metabolism is a newly trend that several consortiums and countries have adopted. The aim of the study is to determine a postprandial triglyceride concentration cut-off point that accurately discriminate individuals with fasting normal triglyceride concentrations from those with fasting hypertriglyceridemia.Entities:
Keywords: Cardiovascular risk; Hypertriglyceridemia; Postprandial triglycerides
Mesh:
Substances:
Year: 2018 PMID: 30021651 PMCID: PMC6052549 DOI: 10.1186/s12944-018-0803-8
Source DB: PubMed Journal: Lipids Health Dis ISSN: 1476-511X Impact factor: 3.876
Fig. 1Triglyceride changes during the Oral Fat Tolerance Test in subjects with or without hypertriglyceridemia. Triglyceride changes during the Oral Fat Tolerance Test stratified by fasting hypertriglyceridemia. 0 Absent, 1 Present
Baseline characteristics (n = 212) of the studied population
| Age (years) | 47.51 ± 12.3 |
|---|---|
| Women | 143 (67.5%) |
| BMIª | 27.9 ± 4.1 |
| Waist (cm) | 92.1 ± 11.0 |
| Waist-hip ratio | 0.90 ± 0.07 |
| Fasting glucose (mg/dL) | 101 (93–111) |
| Fasting insulin (mU/L) | 8.70 (6.3–12.2) |
| Total cholesterol (mg/dL) | 208.9 ± 38.4 |
| Fasting triglycerides (mg/dL) | 183 (130–246) |
| HDL-c (mg/dL) | 44.8 ± 11.8 |
| Aapo-B (mg/dL) | 106.6 ± 25.1 |
| LDL-c (mg/dL) | 127.6 ± 33.1 |
aBMI (Body Mass Index), HDL-c (high density lipoprotein cholesterol), LDL-c (low density lipoprotein cholesterol)
Fig. 2Performance of the postprandial triglycerides value (280 mg/dL) of to discriminate fasting hypertriglyceridemia. a Area Under the ROC curve 0.810 (IC95% 0.773–0.847) bootstrap-corrected c-statistic = 0.733 (IC95% 0.68–0.86) (b) Representation of the discrimination capacity by groups: 1.- True negative: Normo-triglyceridemia (< 150 mg/dL) /Normo postprandial lipemia (< 280 mg/dL), 2.- False negative: Hypertriglyceridemia (> 150 mg/dL) /Normo postprandial lipemia (< 280 mg/dL) 3.- False positive: Normo-triglyceridemia (< 150 mg/dL) / High postprandial lipemia (> 280 mg/dL) 4.-True positive: Hypertriglyceridemia (> 150 mg/dL) / High postprandial lipemia (> 280 mg/dL). (Two column fitting image)
Accuracy of postprandial lipemia cut-off points to discriminate fasting hypertriglyceridemia in overall and stratified populations
| Cut-off point | Population | N | AUC | 95% confidence interval | Sen | Spec | PPV | NPV |
|---|---|---|---|---|---|---|---|---|
| 280 mg/dL | Normal | 52 | 0.831 | (0.725–0.936) | 0.850 | 0.812 | 0.739 | 0.896 |
| Overweight-Obesity | 147 | 0.778 | (0.699–0.857) | 0.831 | 0.725 | 0.890 | 0.617 | |
| ≤ 49 years | 106 | 0.816 | (0.739–0.894) | 0.833 | 0.800 | 0.873 | 0.744 | |
| > 50 years | 98 | 0.786 | (0.697–0.875) | 0.846 | 0.727 | 0.859 | 0.705 | |
| Women | 143 | 0.787 | (0.715–0.858) | 0.824 | 0.750 | 0.852 | 0.709 | |
| Men | 69 | 0.858 | (0.767–0.95) | 0.891 | 0.826 | 0.911 | 0.791 | |
| 200 mg/dL [ | Overall | 212 | 0.700 | (0.644–0.755) | 0.90 | 0.400 | 0.752 | 0.900 |
| 180 mg/dL [ | 212 | 0.593 | (0.548–0.637) | 0.90 | 0.186 | 0.691 | 0.900 | |
| 175 mg/dL [ | 212 | 0.593 | (0.548–0.637) | 0.90 | 0.186 | 0.691 | 0.900 |
aAUC area under the ROC curve, Sen sensibility, Spec specificity, PPV positive predictive value, NPV negative predictive value
Baseline characteristics of sample replication (n = 71)
| Age (years) | 47.7 ± 13.66 |
|---|---|
| Women | 38 (53.5%) |
| BMI ª | 28.5 ± 5 |
| Waist (cm) | 93.9 ± 11.5 |
| Waist-hip ratio | 0.89 ± 0.13 |
| Fasting glucose (mg/dL) | 102 (94–112) |
| Fasting insulin (mU/L) | 9.0 (5.7–13.9) |
| Total cholesterol (mg/dL) | 215.2 ± 46.0 |
| Fasting triglycerides (mg/dL) | 178 (127–241) |
| Hypertriglyceridemia | 41 (57.7%) |
| Familiar combined hyperlipidemia | 23 (32.8%) |
| Hypoalphalipoproteinemia (< 40 mg/dL) | 26 (37.6%) |
| apo B (mg/dL) | 113.7 ± 31.0 |
| HDL-c (mg/dL) | 45.0 ± 13.2 |
| LDL-c (mg/dL) | 128.6 ± 34.1 |
aBMI body mass index), HDL-c (high density lipoprotein cholesterol), LDL-c (low density lipoprotein cholesterol). Hypertriglyceridemia (> 150 mg/dL)
Fig. 3Globorisk scores from patients with high postprandial lipemia. Median Globorisk scores from patients with high postprandial lipemia (> 280 mg/dL) compared to patients with normo postprandial lipemia (< 280 mg/dL) (p < 0.01)